Development of an integrated conceptual model of multiple sclerosis spasticity

被引:2
|
作者
Cameron, Michelle H. [1 ]
Bethoux, Francois [2 ]
Field-Fote, Edelle [3 ,4 ]
Lenderking, William R. [5 ]
Zaiser, Erica [6 ]
Cutts, Katelyn N. [5 ]
Wagner, Joanne M. [7 ,8 ]
Berwaerts, Joris [7 ,8 ]
Steinerman, Joshua R. [9 ,10 ]
机构
[1] OR Hlth & Sci Univ, Dept Neurol, Portland, OR USA
[2] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH USA
[3] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA
[4] Emory Univ, Dept Rehabil Med, Sch Med, Atlanta, GA USA
[5] Evidera, Waltham, MA USA
[6] Evidera, London, England
[7] Greenwich Biosci Inc, Mt Prospect, IL USA
[8] Jazz Pharmaceut, Carlsbad, CA USA
[9] Jazz Pharmaceut Inc, Philadelphia, PA USA
[10] 2005 Market St,Suite 2100, Philadelphia, PA 19103 USA
关键词
Multiple sclerosis; muscle spasticity; conceptual model; qualitative research; interviews; SPINAL-CORD-INJURY; MOBILITY IMPROVEMENT; BOTULINUM TOXIN; SYMPTOMS; BURDEN; SATIVEX; DISEASE; STROKE; IMPACT; PAIN;
D O I
10.1080/09638288.2023.2237403
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
PurposeSpasticity is common in multiple sclerosis (MS), often leading to functional limitations and disability. We developed a conceptual model of spasticity in MS integrating expert opinion, recent literature, and experiences of clinicians and people with MS spasticity.MethodsA conceptual model was developed based on a targeted literature review of articles published between 2014 and 2019, followed by input from clinicians, then input from participants with MS spasticity. Multidisciplinary experts on spasticity provided guidance at each step.ResultsKey concepts of the integrated spasticity conceptual model included: moderators; triggers; modifiers; treatment; objective manifestations; subjective experience; physical, functional, social, and emotional/psychological impacts; and long-term consequences. Participants with MS spasticity most frequently endorsed spasms, tightness, and pain as descriptors of spasticity. Some participants with MS spasticity had difficulty distinguishing spasticity from other MS symptoms (e.g. muscle weakness). Some triggers, emotional/psychological impacts, and long-term consequences of spasticity reported by participants with MS spasticity were not previously identified in the published literature.ConclusionsThis conceptual model of spasticity, integrating published literature with the experience of clinicians, people with MS spasticity, and experts, demonstrates the complex, multidimensional nature of MS spasticity. This model may be used to improve clinician-patient dialogue, research, and patient care.
引用
收藏
页码:2955 / 2965
页数:11
相关论文
共 50 条
  • [1] Consensus document on spasticity in patients with multiple sclerosis
    Oreja-Guevara, Celia
    Montalban, Xavier
    de Andres, Clara
    Casanova-Estruch, Bonaventura
    Munoz-Garcia, Delicias
    Garcia, Inmaculada
    Fernandez, Oscar
    REVISTA DE NEUROLOGIA, 2013, 57 (08) : 359 - 373
  • [2] Sativex® in multiple sclerosis spasticity: a cost-effectiveness model
    Slof, John
    Gras, Adrien
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 525 - 538
  • [3] Pharmacological treatment of spasticity in multiple sclerosis
    Heinzlef, O.
    Monteil-Roch, I.
    REVUE NEUROLOGIQUE, 2012, 168 : S62 - S68
  • [4] Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
    Meuth, Sven G.
    Vila, Carlos
    Dechant, Kerry L.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (08) : 909 - 918
  • [5] Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines
    Gold, Ralf
    Oreja-Guevara, Celia
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 55 - 59
  • [6] Management of symptoms associated with spasticity in patients with multiple sclerosis
    Asuncion Fernandez-Pablos, Maria
    Costa-Frossard, Lucienne
    Garcia-Hernandez, Carlos
    Garcia-Montes, Inmaculada
    Escutia-Roig, Matilde
    ENFERMERIA CLINICA, 2016, 26 (06): : 367 - 373
  • [7] The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity
    Marinelli, Lucio
    Mori, Laura
    Canneva, Stefania
    Colombano, Federica
    Curra, Antonio
    Fattapposta, Francesco
    Bandini, Fabio
    Capello, Elisabetta
    Abbruzzese, Giovanni
    Trompetto, Carlo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 232 - 239
  • [8] Spasticity in multiple sclerosis
    Barnes, MP
    Kent, RM
    Semlyen, JK
    McMullen, KM
    NEUROREHABILITATION AND NEURAL REPAIR, 2003, 17 (01) : 66 - 70
  • [9] Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up
    Stampacchia, Giulia
    Gerini, Adriana
    Mazzoleni, Stefano
    NEUROREHABILITATION, 2016, 38 (04) : 385 - 393
  • [10] Patient-Identified Factors That Influence Spasticity in People with Stroke and Multiple Sclerosis Receiving Botulinum Toxin Injection Treatments
    Cheung, Janice
    Rancourt, Amanda
    Di Poce, Stephanie
    Levine, Amy
    Hoang, Jessica
    Ismail, Farooq
    Boulias, Chris
    Phadke, Chetan P.
    PHYSIOTHERAPY CANADA, 2015, 67 (02) : 157 - 166